Banu, H., Sethi, D.K., Edgar, A., Sheriff, A., Rayees, N., Renuka, N., Faheem, S.M., Premkumar, K. & Vasanthakumar, G. 2015. Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell line. Journal of Photobiology 5: 116-128. https://doi.org/10.1016/j.jphotobiol.2015.05.008

Cai, L., Yu, R., Hao, X. & Ding, X. 2017. Folate receptor-targeted bioflavonoid genistein-loaded chitosan nanoparticles for enhanced anticancer effect in cervical cancers. Nanoscale research Letters 12: 509-518. https://doi.org/10.1186/s11671-017-2253-z

Chanasttru, W., Jones, O.G., Decker, E.A. & McClelements, D.J. 2009. Impact of cosolvents on formation and properties of biopolymer nanoparticles formed by heat treatment of beta-lactoglobulin-pectin complexes. Food Hydrocolloids 23: 2450-2457. https://doi.org/10.1016/j.foodhyd.2009.07.003

Chaudhary, A., Sutaria, D., Huang, Y., Wang, J. & Prabhu, S. 2011. Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nbanotechnology-based combined treatment system. Cancer Prevention Research 4: 1655-1664. https://doi.org/10.1158/1940-6207.CAPR-11-0129

Crott, J.w., Liu, Z., Keyes, M.K., Choi, S. W., Jang, H. & Moyer, M.P. 2008. Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cells line, Mason J B, Journal of Nutritional Biochemistry 19: 328-335. https://doi.org/10.1016/j.jnutbio.2007.05.003

D'Angelica, M., Ammori, J., Gonen, M.S., Klimstra, D.S., Low, P., Murphy, L.R., Weiser, M. B., Paty, I., Fong, Y.P., DeMatteo, R., Allen, P. R. & Jarnagin, J. 2011. Folate receptor-a expression in resectable hepatic colorectal cancer metastases: patterns and significance. Modern Pathology 24: 1221-1228. https://doi.org/10.1038/modpathol.2011.82

Divsalar, A., Saboury, A.A., Mansouri-Torshizi, H. & Moosavi-Movahedi, A.A. 2007a. Binding properties of a new anti-tumor component (2, 2'-bipyridin octylglycinato Pd (II) nitrate) with bovine Beta-lactoglobulin-A and B. Journal of Biomolecular Structure and Dynamics 25: 173-182. https://doi.org/10.1080/07391102.2007.10507166

Divsalar, A., Saboury, A.A., Yousefi, R., Mansouri-Torshizi, H. & Moosavi-Movahedi, A.A. 2007b. Spectroscopic and cytotoxic studies of the novel designed Palladium (II) complexes: Beta-lactoglobulin and K562 as the targets. International Journal of Biological Macromolecules 40: 381-386. https://doi.org/10.1016/j.ijbiomac.2006.09.015

Ebbing, M., Bønaa, K.H., Nygard. O., Arnesen, E., Ueland, P.M., Nordrehaug, J.E., Rasmussen, K., Njølstad, I., Refsum, H., Nilsen, D.W., Tverdal, A., Meyer, K. & Vollset, S.E. 2009. Cancer incidence and mortality after treatment with folic acid and vitamin B12. The Journal of American Medical Association 302: 2119-2126.

Evanse, J.C., Malhotra, M., Guo, J., O'Shea, J., Handrahan, K.O'Neill, A., Landry, W.D., Griffine, B.T., Darcy, R., Waston, W. & O'Driscoll, C.M. 2016. Folate-targeted amphiphilic cyclodextrin siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediat uptake, therapeutice gene silencing in vitro and prolonged circulation in vivo. Nanomedicine: Nanotechnology, Biology and Medicine 12: 2341-2351.Florea, A.N. & Busselberg, D. 2011. Cis platin as an anti-tumor drug: cellular mechanisms of activity, drug resistance & induced side effects. Cancer 3:1351-1371. https://doi.org/10.1016/j.nano.2016.06.014

Franco, A., Sikalidis, J.A. & Herruzo, S. 2005. Colorectal cancer: influence of diet and lifestyle factors. Revista Espanola de Enfermedades Digestivas 97: 432-448. https://doi.org/10.4321/S1130-01082005000600006

Ghalandari, B., Divsalar, A., Saboury, A.A. & Parivar, K. 2014. The new insight into oral drug delivery system based on metal drugs in colon cancer therapy through b-lactoglobulin/oxali-palladium nanocapsules. Journal of Photochemistry and Photobiology B: Biology 140: 255-265. https://doi.org/10.1016/j.jphotobiol.2014.08.003

Ghalandari, B., Divsalar, A., Saboury, A.A., Haertlé, T., Parivar, K., Bazl, R., Eslami-Moghadam, M. & Amanlou, M. 2013. Spectroscopic and theoretical investigation of oxali-palladium interactions with β-lactoglobulin, Spectrochim Acta. A Molecular Biomolecular Spectroscopy Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 118: 1038-46.126. https://doi.org/10.1016/j.saa.2013.09.126

Izadi, Z., Divsalar, A., Saboury, A.A., Sawyer, L. 2016. Beta Lactoglobulin-pectin nanoparticle-based oral drug delivery system for potential treatment of colon. Chemical Biology Drug Design 88: 209-216. https://doi.org/10.1111/cbdd.12748

Jae Lee, S., Hoon, Y., Heon, L.S. & Sig Kim, S. 2012. Oxali-platin nanoparticles and method for preparing same, Bio-Synectics, Inc., Jw Pharmaceutical Corporation, US 20120177728 A1.

Kontopidis, G., Holt, C. & Sawyer, L. 2004. Beta lactoglobulin: Binding properties, structure and function. Journal of Dairy Sciences 87: 785-796. https://doi.org/10.3168/jds.S0022-0302(04)73222-1

Liang, L. & Subirade, M. 2010. Beta lactoglobulin/folic acid complexes. Formation, characterization, and biological implication. Journal of Physical Chemistry: B 114: 6707-6712. https://doi.org/10.1021/jp101096r

Lim, E., Jang, E., Lee, K., Haam, S. & Huh, Y. 2013. Delivery of cancer therapeutics using nanotechnology. Pharmaceutics 5: 294-317. https://doi.org/10.3390/pharmaceutics5020294

Malekzadeh, R., Bishehsari, F., Mahdavinia, M. & Ansari, R. 2009. Epidemiology and Molecular Genetics of Colorectal Cancer in Iran: A Review. Achieve Iranian Medicine 12: 161-169.

Mishra, B. 2010. Colloidal nanocarriers: a review on formulation technology, type and applications toward targeted drug delivery. Nanomedicine/ Nanotechnology, Biology and Medicine 6: 9-24. https://doi.org/10.1016/j.nano.2009.04.008

Peer, D., KarP, J. M., Hong, S., farokhzaD, O.C., Margalit, R. & langer, R. 2007. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology 2: 751-760. https://doi.org/10.1038/nnano.2007.387

Peppase, B. & Blanchette, J. O. 2017. Nanoparticle and targeted system for cancer therapy. Advanced Drug Delivery Reviews 56: 1649-1659. https://doi.org/10.1016/j.addr.2004.02.014

Prince, A., Debaprotim, D., Suravi, P. & Nazneen, D. 2016. A promising approach to support appropriate colon target drug delivery system. World Journal of Pharmacy and Pharmaceutical Sciences 5: 556-568.

Renard, D., Lefebvre, j., Griffin, M.C.A. & Griffin, W.G. 1998. Effects of pH and salt environment on the association of Beta-lactoglobulin revealed by intrinsic fluorescence studies. International Journal of Biological Macromulecules 22: 139-150. https://doi.org/10.1016/S0141-8130(97)00086-X

Shi, J., Votruba, A.R., Farokhzad, O.C. & Langer, R. 2010. Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Letter 10: 3223-3230. https://doi.org/10.1021/nl102184c

Surendiran, A., Sandhiya, S. & Adithan, C. 2009. Novel applications of nanotechnology in medicine. Indian Journal of Medical Research 130: 689-701.

Trujillo, L.E., Ávalos, R., Granda, S., Santiago, G.L. & País-Chanfrau, J.M. 2016. Nanotechnology applications for food and fioprocessing industries. Biological Medicine 8: 1-6.

Waxman, S. & Schereiber, C. 1975. The isolation of the folate binding protein from commercially purified bovine beta lactoglobulin. Febs Letters 75: 244-248.

Zimet, P. & Livney, Y.D. 2009. Beta-lactoglobulin and its nanocomplexes with pectin as vehicles for u-3 polyunsaturated fatty acids. Food Hydrocolloids 23: 1120-1126. https://doi.org/10.1016/j.foodhyd.2008.10.008

Zhang, J., Wang, L., Xing, Z., Liu, D., Sun, J., Li, X. & Zhang, Y. 2010. Status of bi- and multi-nuclear platinum anticancer drug development. Anticancer Agent in Medicinal Chemistry 10: 272-282. https://doi.org/10.2174/187152010791162270

Zou, A., Zhao, X., Ulrich, A.H. & Vasil, M.G. 2017. Folate receptor targeted bufalin / B-cyclodextrin supramolecolar inclusion complex for enhanced solubility and anti-tumor efficiency of bufalin. Materials Science and Engineering C 78: 609-618. https://doi.org/10.1016/j.msec.2017.04.094